Monday, August 22, 2016

Pfizer spends $14B on Medivation in cancer fight

cancers in men and women by adding Medivation's pricey prostate cancer treatment Xtandi to a lineup that already includes the breast cancer … a possible treatment for earlier-stage prostate cancers. Pfizer said Monday that it …

No comments:

Post a Comment